Your browser doesn't support javascript.
loading
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.
Quattrone, Diego; Ferraro, Laura; Tripoli, Giada; La Cascia, Caterina; Quigley, Harriet; Quattrone, Andrea; Jongsma, Hannah E; Del Peschio, Simona; Gatto, Giusy; Gayer-Anderson, Charlotte; Jones, Peter B; Kirkbride, James B; La Barbera, Daniele; Tarricone, Ilaria; Berardi, Domenico; Tosato, Sarah; Lasalvia, Antonio; Szöke, Andrei; Arango, Celso; Bernardo, Miquel; Bobes, Julio; Del Ben, Cristina Marta; Menezes, Paulo Rossi; Llorca, Pierre-Michel; Santos, Jose Luis; Sanjuán, Julio; Tortelli, Andrea; Velthorst, Eva; de Haan, Lieuwe; Rutten, Bart P F; Lynskey, Michael T; Freeman, Tom P; Sham, Pak C; Cardno, Alastair G; Vassos, Evangelos; van Os, Jim; Morgan, Craig; Reininghaus, Ulrich; Lewis, Cathryn M; Murray, Robin M; Di Forti, Marta.
Afiliação
  • Quattrone D; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, UK.
  • Ferraro L; National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, King's College London, London, UK.
  • Tripoli G; Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.
  • La Cascia C; Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Via G. La Loggia 1, 90129Palermo, Italy.
  • Quigley H; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
  • Quattrone A; Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Via G. La Loggia 1, 90129Palermo, Italy.
  • Jongsma HE; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
  • Del Peschio S; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98100, Messina, Italy.
  • Gatto G; Psylife Group, Division of Psychiatry, University College London, 6th Floor, Maple House, 149 Tottenham Court Road, London, W1T 7NF, UK.
  • Gayer-Anderson C; University of Bologna, 40126Bologna, Italy.
  • Kirkbride JB; Department of Health Service and Population Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
  • La Barbera D; Department of Psychiatry, University of Cambridge, Herchel Smith Building for Brain & Mind Sciences, Forvie Site, Robinson Way, Cambridge, CB2 0SZ, UK.
  • Tarricone I; CAMEO Early Intervention Service, Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge, CB21 5EF, UK.
  • Berardi D; Psylife Group, Division of Psychiatry, University College London, 6th Floor, Maple House, 149 Tottenham Court Road, London, W1T 7NF, UK.
  • Tosato S; Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Via G. La Loggia 1, 90129Palermo, Italy.
  • Lasalvia A; Department of Medical and Surgical Science, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, Viale Pepoli 5, 40126Bologna, Italy.
  • Szöke A; Department of Medical and Surgical Science, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, Viale Pepoli 5, 40126Bologna, Italy.
  • Arango C; Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Piazzale L.A. Scuro 10, 37134Verona, Italy.
  • Bernardo M; Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Piazzale L.A. Scuro 10, 37134Verona, Italy.
  • Bobes J; INSERM, U955, Equipe 15, 51 Avenue de Maréchal de Lattre de Tassigny, 94010 Créteil, France.
  • Del Ben CM; Child and Adolescent Psychiatry Department, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, C/Doctor Esquerdo 46, 28007Madrid, Spain.
  • Menezes PR; Department of Medicine, Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
  • Llorca PM; Faculty of Medicine and Health Sciences - Psychiatry, Universidad de Oviedo, ISPA, INEUROPA. CIBERSAM, Oviedo, Spain.
  • Santos JL; Department of Preventative Medicine, Faculdade de Medicina FMUSP, University of São Paulo, São Paulo, Brazil.
  • Sanjuán J; Department of Preventative Medicine, Faculdade de Medicina FMUSP, University of São Paulo, São Paulo, Brazil.
  • Tortelli A; EA 7280 Npsydo, Université Clermont Auvergne, Clermont-Ferrand, France.
  • Velthorst E; Department of Psychiatry, Servicio de Psiquiatría Hospital 'Virgen de la Luz', Cuenca, Spain.
  • de Haan L; Department of Psychiatry, School of Medicine, Universidad de Valencia, Centro de Investigación Biomédica en Red de Salud Mental, Valencia, Spain.
  • Rutten BPF; Etablissement Public de Santé Maison Blanche, Paris, France.
  • Lynskey MT; Department of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
  • Freeman TP; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Sham PC; Department of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
  • Cardno AG; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
  • Vassos E; National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 4 Windsor Walk, London, SE5 8BB, UK.
  • van Os J; National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 4 Windsor Walk, London, SE5 8BB, UK.
  • Morgan C; Department of Psychology, University of Bath, 10 West, Bath, BA2 7AY, UK.
  • Reininghaus U; Department of Psychiatry, The University of Hong Kong, Hong Kong, China.
  • Lewis CM; Li KaShing Faculty of Medicine, Centre for Genomic Sciences, The University of Hong Kong, Hong Kong, China.
  • Murray RM; Academic Unit of Psychiatry and Behavioural Sciences, University of Leeds, Leeds, UK.
  • Di Forti M; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, UK.
Psychol Med ; 51(8): 1329-1337, 2021 06.
Article em En | MEDLINE | ID: mdl-32183927
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Problema de saúde: 2_sustancias_psicoativas / 8_cannabis_related_disorders / 8_cocaine_other_stimulant_related_disorders Assunto principal: Transtornos Psicóticos / Esquizofrenia / Cannabis / Abuso de Maconha Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Psychol Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Problema de saúde: 2_sustancias_psicoativas / 8_cannabis_related_disorders / 8_cocaine_other_stimulant_related_disorders Assunto principal: Transtornos Psicóticos / Esquizofrenia / Cannabis / Abuso de Maconha Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Psychol Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido